Clinical Professor Michaela Lucas is a Clinical Immunologist/Allergist and Immunopathologist and Clinician-Scientist with conjoint appointments with Sir Charles Gairdner Hospital, Pathwest, the Perth Children’s Hospital, and The University of Western Australia, where she leads a multi-disciplinary team of clinical and basic science researchers, microsurgeons and technicians, at the Immunology and Transplantation Lab. After completing medical training in Germany, she received a Marie Curie Research Fellowship and undertook a four-year postdoctoral position at the University of Oxford where she studied liver T-cell immunology. Her research interests and expertise span T cell immunology including the pathogenesis of T cell mediated drug allergies, anti-viral T cell responses, vaccine development, and most recently understanding the role of inflammation in the development of adaptive immunity in organ transplantation, and the impacts of plastics exposure to human health.

Professor Lucas’s research has produced over 100 peer-reviewed papers. She has held multiple national and international research grants as a principle and co-investigator. In addition, Professor Lucas is conducting two investigator-driven randomised controlled trials in antibiotic allergy. She is a leading clinician in the field of Drug Allergy Management in Australia, and is the President of the Australasian Society of Immunology and Allergy (ASCIA), and the project lead in Drug Allergy for the National Allergy Strategy.